Zyprexa Related Published Studies
Well-designed clinical trials related to Zyprexa (Olanzapine)
Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. [2008.10]
Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study. [2008.08]
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. [2008.08]
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. [2008.07]
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study. [2008.06.30]
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. [2008.06]
Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. [2008.06]
Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study. [2008.05.30]
Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. [2008.05]
Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. [2008.05]
Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia. [2008.05]
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. [2008.05]
An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. [2008.05]
An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. [2008.04.29]
Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine. [2008.04]
Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. [2008.04]
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial. [2008.03.11]
Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. [2008.03.01]
Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. [2008.03]
Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. [2008.03]
Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. [2008.02.15]
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. [2008.02]
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. [2008.02]
Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. [2008.02]
A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels. [2008.02]
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naive population. [2008.02]
Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. [2008.01.31]
Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial. [2008.01.30]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. [2008.01]
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. [2008.01]
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. [2007.12]
Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. [2007.12]
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?-A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. [2007.12]
Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine. [2007.11]
Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study. [2007.11]
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms. [2007.11]
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. [2007.11]
Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. [2007.10.27]
Olanzapine versus placebo in the treatment of adolescents with bipolar mania. [2007.10]
Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation. [2007.10]
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. [2007.10]
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. [2007.09]
Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. [2007.08]
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study. [2007.08]
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial. [2007.07.25]
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. [2007.07]
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. [2007.07]
Olanzapine therapy in anorexia nervosa: psychobiological effects. [2007.07]
Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol. [2007.07]
Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial. [2007.07]
Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. [2007.07]
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. [2007.06]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2007.05.23]
Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion? [2007.05]
Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. [2007.04]
The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study. [2007.03.30]
A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. [2007.03]
A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania. [2007.03]
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin. [2007.03]
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. [2007.02.20]
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. [2007.02]
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. [2007.02]
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial. [2007.01.05]
The role of olanzapine in the treatment of anorexia nervosa. [2007.01]
Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study. [2007.01]
Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. [2006.12.30]
Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine. [2006.12]
Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. [2006.12]
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. [2006.11]
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial. [2006.11]
Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. [2006.10.21]
ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder. [2006.10]
A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. [2006.10]
The early effect of olanzapine and risperidone on insulin secretion in atypical-naive schizophrenic patients. [2006.10]
Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning. [2006.10]
Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. [2006.10]
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. [2006.09]
Olanzapine and haloperidol in first episode psychosis: two-year data. [2006.09]
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. [2006.08]
Asian outpatients with schizophrenia: a double-blind randomized comparison of quality of life and clinical outcomes for patients treated with olanzapine or haloperidol. [2006.08]
An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia. [2006.08]
Plasma concentrations of high-dose olanzapine in a double-blind crossover study. [2006.08]
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. [2006.08]
A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. [2006.07]
Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. [2006.07]
A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. [2006.07]
Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia. [2006.06]
Early predictors of substantial weight gain in bipolar patients treated with olanzapine. [2006.06]
A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia. [2006.06]
Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. [2006.06]
The effect of olanzapine on craving and alcohol consumption. [2006.06]
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects. [2006.06]
A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. [2006.05]
A single-blind, randomized comparison of olanzapine at a starting dose of 5 mg versus 20 mg in acute schizophrenia. [2006.05]
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. [2006.05]
Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. [2006.04]
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. [2006.04]
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. [2006.04]
|
